(Q38026305)

27 August 2017

title

Review of miR-200b and cancer chemosensitivity (English)

1 reference

27 August 2017

Review of MiR-200b and cancer chemosensitivity (English)

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

6 January 2025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22795796

antineoplastic resistance

6 January 2025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22795796

6 January 2025

author name string

Bing Feng

1

1 reference

27 August 2017

Rui Wang

2

1 reference

27 August 2017

Long-Bang Chen

3

1 reference

27 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22795796

6 January 2025

publication date

29 June 2012

1 reference

full work available at URL

27 August 2017

https://api.elsevier.com/content/article/PII:S0753332212000650?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

https://api.elsevier.com/content/article/PII:S0753332212000650?httpAccept=text/plain

6 January 2025

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Biomedicine and Pharmacotherapy

6 January 2025

published in

1 reference

27 August 2017

volume

66

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

397-402

1 reference

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

27 August 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.YGYNO.2008.04.033

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/JCB.23150

Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.CANLET.2011.03.012

Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective.

1

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Chemotherapy resistance in breast cancer

6 January 2025

2

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay.

6 January 2025

3

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA expression profiles for the NCI-60 cancer cell panel

6 January 2025

4

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

6 January 2025

5

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

6 January 2025

6

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells

6 January 2025

7

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

6 January 2025

8

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

6 January 2025

9

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

6 January 2025

10

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA signatures in human ovarian cancer

6 January 2025

11

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion

6 January 2025

13

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

6 January 2025

14

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells

6 January 2025

15

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

6 January 2025

16

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

6 January 2025

17

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels

6 January 2025

18

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

6 January 2025

19

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro

6 January 2025

20

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

6 January 2025

22

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

6 January 2025

23

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1).

6 January 2025

24

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA‐200b reverses chemoresistance of docetaxel‐resistant human lung adenocarcinoma cells by targeting E2F3

6 January 2025

25

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA expression profiles in serous ovarian carcinoma.

6 January 2025

26

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Epithelial-mesenchymal transitions in tumour progression

6 January 2025

27

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

6 January 2025

28

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

6 January 2025

29

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.

6 January 2025

30

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

6 January 2025

31

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

6 January 2025

32

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

6 January 2025

33

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

6 January 2025

34

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

6 January 2025

35

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

6 January 2025

37

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies

6 January 2025

38

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

The epithelial-mesenchymal transition generates cells with properties of stem cells

6 January 2025

39

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

6 January 2025

40

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Polycomb complexes repress developmental regulators in murine embryonic stem cells

6 January 2025

41

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Control of developmental regulators by Polycomb in human embryonic stem cells

6 January 2025

42

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

6 January 2025

43

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.

6 January 2025

44

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

6 January 2025

45

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer

6 January 2025

46

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness

6 January 2025

48

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

6 January 2025

49

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Antiangiogenic therapy: a universal chemosensitization strategy for cancer?

6 January 2025

52

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Current status of angiogenesis inhibitors combined with radiation therapy

6 January 2025

53

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers

6 January 2025

55

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Regulation of vascular endothelial growth factor signaling by miR-200b.

6 January 2025

56

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells

6 January 2025

57

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Transcription factor 8 activates R-Ras to regulate angiogenesis

6 January 2025

58

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis

6 January 2025

59

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Apoptosis in cancer--implications for therapy

6 January 2025

60

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

miRNAs in cancer: approaches, aetiology, diagnostics and therapy

6 January 2025

62

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells

6 January 2025

63

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Taxol suppresses dynamics of individual microtubules in living human tumor cells

6 January 2025

65

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Paclitaxel-induced cell death: where the cell cycle and apoptosis come together

6 January 2025

66

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Tumoral and tissue-specific expression of the major human beta-tubulin isotypes

6 January 2025

67

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel

6 January 2025

68

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III beta-tubulin

6 January 2025

69

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

6 January 2025

70

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells

6 January 2025

71

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells

6 January 2025

72

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

EMT and Stem Cell–Like Properties Associated with miR-205 and miR-200 Epigenetic Silencing Are Early Manifestations during Carcinogen-Induced Transformation of Human Lung Epithelial Cells

6 January 2025

73

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet

6 January 2025

74

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription

6 January 2025

75

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

6 January 2025

76

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Smad3 regulates E-cadherin via miRNA-200 pathway

6 January 2025

77

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

6 January 2025

78

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

6 January 2025

79

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?

6 January 2025

80

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

LNA-modified oligonucleotides mediate specific inhibition of microRNA function.

6 January 2025

81

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

Silencing of microRNAs in vivo with 'antagomirs'

6 January 2025

82

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

6 January 2025

83

1 reference

https://api.crossref.org/works/10.1016/J.BIOPHA.2012.06.002

6 January 2025

Identifiers

1 reference

27 August 2017

1 reference